Life Insurance
Consensus Index

AI Consensus Fit Review

Corebridge Financial Life Insurance After a Heart Attack Fit Review

Corebridge Financial is a mixed-to-good fit for Life Insurance After a Heart Attack, depending on how long ago the event occurred and how strong the applicant's current cardiac profile is.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Corebridge Financial is a mixed-to-good fit for Life Insurance After a Heart Attack, depending on how long ago the event occurred and how strong the applicant's current cardiac profile is. Three of seven platforms named Corebridge during the ranking stage (google, grok, perplexity), and all seven evaluated it at the fit stage, with four rating it "good" and three rating it "mixed." The strongest reason to consider it is a dual product path: guaranteed-issue and simplified-issue whole life for applicants who cannot qualify for traditional underwriting, plus medically underwritten Select-a-Term and QoL Flex Term for recovered applicants. The main limitation is that no platform found publicly documented, heart-attack-specific underwriting rules, ejection-fraction thresholds, or post-event pricing from Corebridge.

Research Snapshot

FieldDetail
Platform mentions in ranking stage3 of 7 platforms (google, grok, perplexity)
Share of included platform responses42.9%
Average listed rank4.0
Best listed rank1 (google)
Relevant product/model/planSelect-a-Term, QoL Flex Term, Guaranteed Issue Whole Life (GIWL), SimpliNow Legacy simplified issue, underwritten term and universal life
Overall use-case fitMixed to good; four platforms rated "good," three rated "mixed"
Research date2026-09-22

Why Corebridge Financial Qualified for This Study

Questions This Section Answers

  • Why did Corebridge Financial qualify as a life insurance carrier worth considering after a heart attack?
  • How many AI platforms named Corebridge Financial for life insurance after a heart attack?

Corebridge Financial qualified because it was named by three of the seven included platforms during ranking discovery and was then evaluated by all seven at the fit stage. Google ranked it first, grok ranked it fourth, and perplexity ranked it seventh, producing an average listed rank of 4.0 [1]. The remaining four platforms (openai, anthropic, deepseek, kimi) did not name it in the ranking stage but still produced full fit assessments, so the fit evidence base is broader than the ranking count suggests.

The company's relevance to this use case rests on product breadth rather than a dedicated cardiac program. Corebridge publicly lists term, permanent, and final-expense life insurance [2], and its final-expense materials identify SimpliNow Legacy and Guaranteed Issue Whole Life Insurance [2]. Independent reviews describe Corebridge as suitable for applicants with heart conditions [4] and as having more flexible underwriting for cardiac cases than some competitors [6].

Corebridge is the former AIG life insurance and retirement business, spun off in 2022 and headquartered in Houston, Texas [8]. It carries an A.M. Best financial strength rating of A (Excellent) [9].

The Product, Model, Plan, or Service Most Relevant to Life Insurance After a Heart Attack

Questions This Section Answers

  • Which Corebridge Financial product should a buyer choose after a heart attack if they cannot qualify for traditional underwriting?
  • Is Corebridge Financial's Guaranteed Issue Whole Life policy a good option for a heart attack survivor who needs coverage quickly?

No single Corebridge product is the answer for every post-heart-attack buyer; the relevant product depends on time since the event and cardiac stability. Platforms converged on a two-path structure.

Path 1 — Guaranteed issue and simplified issue. Corebridge's Guaranteed Issue Whole Life (GIWL) is described as available without a medical exam and designed for seniors [11]. Independent reviews report GIWL covers ages 50 to 80 with face amounts from $5,000 to $25,000 [13]. SimpliNow Legacy is described as simplified issue, requiring no medical exam, with decisions potentially made quickly, but Corebridge states coverage remains subject to underwriting and is not guaranteed [15]. Independent reviews report simplified-issue whole life limits up to about $35,000 for some applicants [17].

Path 2 — Medically underwritten term and permanent. Select-a-Term is described as flexible term insurance with multiple term periods and renewal or conversion possibilities [19]. Independent reviews report 18 term-length options, including 10 years, any annual term from 15 to 30 years, or 35 years [20]. QoL Flex Term includes a Critical Illness Rider covering heart attack, stroke, invasive cancer, organ transplant, and ALS, available for ages 20–59 [22]. QoL Flex Term costs more than Select-a-Term, but the added protection may be worth it [24].

One naming conflict matters for buyers: the ranking stage referenced "QoL Flex Term," but openai's review of current Corebridge public pages did not clearly identify a current consumer product page or confirm availability for new U.S. applicants in the buyer's state (openai, factual_conflicts_or_uncertainty). Corebridge's public pages also use both "Corebridge Direct" and references to "AIG Direct," so the current distribution name and application channel should be confirmed (openai, factual_conflicts_or_uncertainty).

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Corebridge Financial for life insurance after a heart attack?
  • Does Corebridge Financial offer a no-medical-exam life insurance option for heart attack survivors?

Several findings drew broad agreement across platforms.

Guaranteed-issue availability. Corebridge offers a no-medical-exam guaranteed-issue path. Corebridge states Guaranteed Issue Whole Life Insurance is available without a medical exam and is designed for seniors [25], and states guaranteed issue life insurance is available if age qualifications are met and does not require medical underwriting [26]. Independent reviews confirm the product exists with age and face-amount bands [27].

Two-year graded death benefit. Multiple platforms agreed that guaranteed-issue products pay a limited benefit in the first two years. Corebridge states Guaranteed Issue Whole Life Insurance and SimpliNow Legacy provide a limited death benefit during the first two policy years, stated as 110% of premiums paid if death occurs in that period [25]. Independent reviews describe the same structure: a two-year graded death benefit, with 110% of premiums paid if death occurs in the first two years, and the full face amount payable for any cause after two years [28]. Google's review adds that accidental death is fully covered from day one [32].

Coverage limits on no-exam products. Platforms agreed that guaranteed-issue and simplified-issue coverage is modest. Reported ranges are roughly $5,000–$25,000 for guaranteed issue and up to about $35,000 for some simplified-issue products [27].

Underwriting reviews medical history. Corebridge describes traditional underwriting as considering medical history, diagnoses, medications, medical records, laboratory results, lifestyle, and related risk information [35]. Independent sources note heart attack history is a major underwriting factor and carriers evaluate time since event, age, treatment, testing, and current heart function [37].

Financial strength. Corebridge holds an A.M. Best financial strength rating of A (Excellent) [38].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Do AI platforms disagree about whether Corebridge Financial is a good choice for life insurance after a heart attack?
  • What is unclear about Corebridge Financial's heart attack underwriting rules and waiting periods?

Fit ratings split. Four platforms rated Corebridge "good" (anthropic, google, grok, kimi); three rated it "mixed" (openai, deepseek, perplexity). This is a majority-leaning-good but not unanimous picture, and platform agreement does not prove product quality.

Waiting period after the heart attack. Google's review cites a Corebridge field underwriting guide excluding applicants with a heart attack in the last 6 months from automated and expedited pathways [40] and states Corebridge requires a minimum 6-month wait before traditional underwritten coverage [41]. Grok reports Corebridge typically postpones applications under 6–12 months post-event [42]. Independent sources outside Corebridge give wider ranges: 6 to 12 months before applying for traditional coverage [43] and most people qualifying 12 to 24 months post-event [45]. No platform found a Corebridge-published, heart-attack-specific waiting period.

Ejection fraction thresholds. Independent sources describe general industry patterns: mild reduction (45–54%) may qualify for traditional coverage with a rating; moderate reduction (35–44%) typically means higher table ratings or simplified issue; below 35% usually requires guaranteed issue [46]. Google's review notes underwriters look heavily at left ventricular ejection fraction, ideally 50%+ [49]. No platform found Corebridge-published ejection-fraction thresholds.

SimpliNow reliability. Company marketing emphasizes simplified and agile underwriting [50], while independent reviews state SimpliNow often declines healthy applicants for vague reasons and is not reliable for even slightly complex health profiles [52]. This is a direct conflict between owned and independent evidence.

Recent underwriting trend. Grok cites reports of less aggressive offers for impaired risk, including heart disease, in 2024–2025 [54], which conflicts with other platforms describing Corebridge as favorable for cardiac cases [42].

Accelerated underwriting applicability. Independent reviews report over 60% of term applications qualify for AU+ (accelerated underwriting), but the final decision may require labs or records [57], and Corebridge materials indicate AU+ may pivot to full underwriting with labs and physical measurements if the streamlined process cannot support a decision [58]. Whether a post-heart-attack applicant can use AU+ or is routed to full underwriting was not confirmed by any platform.

Customer service. Independent reviews report a high number of customer complaints to regulators, low J.D. Power satisfaction ratings, and a 3.1-out-of-5 overall performance score [59], and one review states Corebridge did not rank among the best life insurance companies because of its high level of complaints [62].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does Corebridge Financial offer that matter to a heart attack survivor buying life insurance?
  • Does Corebridge Financial's critical illness rider cover a future heart attack?

The features most relevant to a post-heart-attack buyer are the critical illness rider, term-length flexibility, conversion privileges, and the guaranteed-issue fallback.

Critical Illness Rider. The rider covers heart attack, stroke, invasive cancer, organ transplant, and ALS, and is available for ages 20–59 with face amounts from $100,000+ [63]. It allows access to funds if the buyer has a major event like a heart attack, stroke, or invasive cancer [64]. This is part of the QoL Flex Term product [63]. One unresolved question: whether the rider can be added to a term policy purchased at age 60+, past the stated age-59 limit, was not confirmed (anthropic, factual_conflicts_or_uncertainty).

Term-length flexibility. Independent reviews report 18 term-length possibilities, including 10 years, any annual term from 15 to 30 years, or 35 years [65]. This lets a buyer align coverage with a recovery timeline and financial obligations.

Conversion privileges. Select-a-Term policies are described as fully convertible to permanent coverage without a medical exam by the end of the level-premium period or age 70, whichever comes first; QoL Flex Term is described as fully convertible to a permanent QoL policy on the same terms (anthropic, pricing_and_terms). Conversion matters for a buyer whose cardiac status could worsen later.

Accelerated benefit riders. Corebridge states some final-expense policies include accelerated benefit riders, but availability, eligibility, and the amount accessible are product- and state-specific and should not be assumed to cover a future cardiac event [67].

Policy delivery speed. Corebridge states the application process is streamlined and can provide an underwriting decision along with policy delivery in 24–48 hours [69]. Independent reviews report real-time approvals on Select-a-Term and QoL policies via SimpliNow Choice, with eligible applicants approved and receiving a policy within hours [70]. Whether the 24–48-hour timeline applies to post-heart-attack applications requiring medical-records review was not confirmed (anthropic, factual_conflicts_or_uncertainty).

Issuing insurers. Corebridge states life policies are issued by American General Life Insurance Company, except in New York where The United States Life Insurance Company in the City of New York may issue them; guarantees depend on the issuing insurer's claims-paying ability [68].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Corebridge Financial life insurance cost per month after a heart attack?
  • Are there setup, cancellation, or graded-benefit costs with Corebridge Financial after a heart attack?

No platform could verify an applicant-specific Corebridge premium for a post-heart-attack buyer. Pricing confidence was rated "low" by openai, anthropic, grok, perplexity, and deepseek; kimi rated it "moderate" (platform pricing_and_terms fields).

Published rate references. Corebridge advertises $250,000 of term life coverage for as low as $13 per month [72]. This is a promotional rate tied to an unspecified age and optimal health profile and does not represent a post-heart-attack price. Independent sources report table ratings common after a heart attack, with each table adding roughly 25% to standard premium [73], and grok reports competitive offers often at Table 4–6 depending on time since event, recovery, and cardiac workups [75].

Guaranteed-issue cost. Corebridge warns that premiums paid for final-expense coverage may cumulatively exceed the policy's face amount [76]. Independent reviews describe guaranteed issue as the most expensive per-dollar coverage option, citing sample rates such as $120/month for a 65-year-old female and $156/month for a 65-year-old male for $20,000 of coverage [77]. These are third-party sample figures, not Corebridge-published rates.

Fees. No separate application fee was identified in reviewed public materials (openai, pricing_and_terms; perplexity, pricing_and_terms). Policy-specific charges, riders, loans, cash-value costs, or administrative charges must be confirmed in the illustration and contract (openai, pricing_and_terms). Administrative fees are deducted if living benefits (accelerated riders) are exercised (google, pricing_and_terms).

Contract terms. Guaranteed-issue and simplified-issue products have a limited death benefit during the first two years [78]. Term coverage may be renewable or convertible depending on the specific policy (openai, pricing_and_terms). Google's review states GIWL is a permanent policy with premiums stopping at age 90, a two-year graded natural-death limit, and a lifetime suicide exclusion [80]. State-specific forms, free-look rights, lapse rules, surrender provisions, and conversion deadlines were not verified for a specific quote (openai, pricing_and_terms; deepseek, pricing_and_terms).

Price transparency. Independent reviews state many policies require working with a financial professional or agent, which may be less convenient for self-service buyers, and the lack of instant online pricing can make cost comparison harder [81]. One review states the only way to find out what you'll pay is to contact an agent directly [83]. Corebridge may offer online quotes for certain term and final-expense policies, but quotes are not fully self-service for every policy [84].

Best Suited For

Questions This Section Answers

  • Who is Corebridge Financial best suited for after a heart attack?
  • Is Corebridge Financial a good choice for a heart attack survivor who needs final-expense coverage?

Corebridge is best suited to buyers who want more than one underwriting route available at a single carrier. Platform fit assessments converge on these groups:

  • Applicants who may be declined or heavily rated by traditional underwriting and need a guaranteed-issue fallback (openai, fit_assessment; perplexity, fit_assessment).
  • Applicants seeking smaller final-expense coverage who accept limited first-two-year benefits (openai, fit_assessment; kimi, fit_assessment).
  • Applicants whose heart attack occurred sufficiently long ago and whose current medical records support conventional underwriting (openai, fit_assessment; anthropic, fit_assessment).
  • Heart attack survivors roughly 1–2+ years post-event with stable cardiac function and good medication compliance seeking flexible term coverage (anthropic, fit_assessment).
  • Applicants wanting custom term lengths (10–35 years) aligned with recovery timeline and financial obligations (anthropic, fit_assessment).
  • Post-heart-attack patients interested in critical illness living benefits to access funds during future cardiac events (anthropic, fit_assessment).
  • Ages 50–80 with limited coverage needs seeking guaranteed-issue final-expense coverage without a medical exam (anthropic, fit_assessment; google, fit_assessment).
  • Applicants at least 6 months post-heart-attack with stable cardiac test results, such as a normal ejection fraction (google, fit_assessment).
  • Buyers who want to ladder from guaranteed issue to better products as health stabilizes (kimi, fit_assessment).

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Corebridge Financial for life insurance after a heart attack?
  • Is Corebridge Financial a poor fit for a buyer who needs large coverage right after a heart attack?

Corebridge is probably not the best fit for several buyer profiles, based on platform fit assessments:

  • Applicants needing large, low-cost income-replacement coverage immediately after a recent or medically complicated heart attack (openai, fit_assessment; anthropic, fit_assessment).
  • Applicants seeking guaranteed-issue coverage with full death benefits from the first day (openai, fit_assessment).
  • Applicants who need an independent broker to identify the most favorable cardiac underwriting class across the market (openai, fit_assessment).
  • Heart attack survivors less than 6–12 months post-event with acute cardiac complications or unstable ejection fraction (anthropic, fit_assessment; google, fit_assessment).
  • Applicants requiring guaranteed-issue coverage above $25,000–$35,000 without qualifying for underwritten products (anthropic, fit_assessment).
  • Those with significant ejection-fraction impairment (below 35%) unable to qualify for traditional underwriting (anthropic, fit_assessment).
  • Consumers preferring fully online, self-service purchase without mandatory agent interaction (anthropic, fit_assessment).
  • Applicants seeking permanent lifetime coverage, since Corebridge term focus limits whole life options to small face amounts (anthropic, fit_assessment).
  • Cardiac survivors under age 40, where other carriers may be more receptive (google, fit_assessment).
  • Buyers who prioritize customer service quality, given reported high complaint levels (anthropic, fit_assessment).

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Corebridge Financial for a heart attack survivor who needs large coverage?
  • When should a buyer choose a different carrier or broker instead of Corebridge Financial after a heart attack?

Several platform assessments identified situations where another option may serve the buyer better.

When the heart attack was remote and cardiac status is favorable. Another carrier or an independent broker may obtain a better cardiac underwriting offer, especially when the heart attack occurred several years ago and follow-up testing, heart function, medications, and lifestyle are favorable (openai, better_alternative_when). A conventional term carrier may be better when the buyer needs substantial income-replacement coverage and can qualify after full underwriting (openai, better_alternative_when).

When immediate acceptance is the priority. A guaranteed-issue specialist may be better when immediate acceptance is the primary objective and the buyer accepts small coverage and graded benefits (openai, better_alternative_when). A specialist guaranteed-issue final-expense carrier may be a better match for recent or complex post-MI history when only final-expense coverage is needed (perplexity, better_alternative_when).

When coverage limits are the constraint. If the applicant requires guaranteed-issue coverage exceeding $25,000, competitors may offer higher limits (anthropic, better_alternative_when). If the buyer needs a larger death benefit than Corebridge's no-exam products provide, another insurer with broader simplified-issue limits may be better (perplexity, better_alternative_when).

When living benefits matter and the buyer is 60+. The QoL Flex Term age limit of 59 eliminates the critical illness rider for older buyers, so a carrier offering living benefits past that age may be preferable (anthropic, better_alternative_when).

When transparency and service matter. Buyers who prefer fully transparent online quotes and self-service purchase without mandatory agent engagement may prefer another carrier (anthropic, better_alternative_when). Buyers who prioritize customer service quality over product flexibility may also look elsewhere, given Corebridge's reported complaint levels (anthropic, better_alternative_when).

When employer coverage is available. A group life policy through an employer may be better when available with limited or no medical underwriting (openai, better_alternative_when).

When published cardiac criteria matter. Buyers seeking carriers with published ejection-fraction guidelines and transparent cardiac underwriting criteria may need to look beyond Corebridge, since no platform found those published (anthropic, better_alternative_when; deepseek, better_alternative_when).

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Corebridge Financial before signing a life insurance contract after a heart attack?
  • Which cardiac details does Corebridge Financial need before it can quote a heart attack survivor?

Platforms produced overlapping verification lists. The recurring items:

  1. Is the exact product available in the buyer's state, and which legal insurer will issue the policy? (openai, questions_to_verify_before_buying; perplexity, questions_to_verify_before_buying)
  2. Does the product accept applicants with a prior heart attack, and is there a required time since the event? (openai, questions_to_verify_before_buying; anthropic, questions_to_verify_before_buying)
  3. How will the underwriter evaluate age at the heart attack, stents or bypass surgery, ejection fraction, stress-test or echocardiogram results, medications, smoking, diabetes, and subsequent cardiac events? (openai, questions_to_verify_before_buying; anthropic, questions_to_verify_before_buying)
  4. Will the application require an attending-physician statement, medical records, prescription database review, exam, labs, or cardiac testing? (openai, questions_to_verify_before_buying; perplexity, questions_to_verify_before_buying)
  5. What are the maximum face amount, issue-age limits, premium schedule, and renewal or conversion provisions? (openai, questions_to_verify_before_buying; perplexity, questions_to_verify_before_buying)
  6. For guaranteed-issue or simplified-issue coverage, exactly what is payable during the first two years, and when does the full death benefit begin? (openai, questions_to_verify_before_buying; kimi, questions_to_verify_before_buying)
  7. Are there exclusions, graded benefits, contestability provisions, suicide limitations, policy loans, surrender charges, or accelerated-benefit reductions? (openai, questions_to_verify_before_buying; perplexity, questions_to_verify_before_buying)
  8. Can the buyer obtain an informal or tentative underwriting assessment before submitting a formal application? (openai, questions_to_verify_before_buying; anthropic, questions_to_verify_before_buying)
  9. What are the guaranteed premiums and non-guaranteed elements for any universal-life illustration? (openai, questions_to_verify_before_buying)
  10. How does the quote compare with at least two other carriers or an independent broker's cardiac-market search? (openai, questions_to_verify_before_buying; kimi, questions_to_verify_before_buying)

Additional items raised by individual platforms: whether the QoL Flex Term critical illness rider can be added at age 62, past the stated age-59 limit (anthropic, questions_to_verify_before_buying); whether the "24–48 hour policy delivery" timeline applies to post-MI underwritten applications (anthropic, questions_to_verify_before_buying); whether a SimpliNow Choice decline can be reviewed by the traditional underwriting team (anthropic, questions_to_verify_before_buying); and whether the lifetime suicide exclusion on the guaranteed-issue policy is acceptable compared with other graded carriers (google, questions_to_verify_before_buying).

Final AI Consensus Verdict

Corebridge Financial is a mixed-to-good fit for life insurance after a heart attack, with the split reflecting genuine uncertainty rather than a clear verdict. Four of seven platforms rated it "good" and three rated it "mixed." The strongest case for Corebridge is its dual path: a guaranteed-issue and simplified-issue fallback for applicants who cannot qualify for traditional underwriting, plus medically underwritten Select-a-Term and QoL Flex Term for recovered applicants, with a critical illness rider that covers future heart attacks for buyers aged 20–59. The strongest case against relying on it alone is the absence of publicly documented, heart-attack-specific underwriting rules, waiting periods, ejection-fraction thresholds, and pricing, combined with reported high complaint levels and agent-dependent quoting.

The practical conclusion supported by the evidence: treat Corebridge as one candidate among several. If the heart attack was remote and current cardiac status is stable, seek a fully underwritten term or permanent quote and compare Corebridge against multiple carriers. If the event was recent or the cardiac profile is complex, Corebridge's guaranteed-issue path is a legitimate fallback, but the two-year graded benefit, low face amounts, and high per-dollar cost should be weighed against specialist guaranteed-issue carriers. Corebridge should not be selected solely because it advertises fast or no-exam coverage.

How This Review Was Produced

This review synthesizes fit-research responses from seven AI platforms (openai, anthropic, google, grok, deepseek, kimi, perplexity) collected for the topic "Best Life Insurance After a Heart Attack" with a research date of 2026-09-22. Each platform was asked which life insurance carriers are generally worth considering after a heart attack and why. Corebridge Financial was named during ranking discovery by three platforms and evaluated at the fit stage by all seven. Fit ratings, product identifications, pricing statements, and verification questions were extracted from platform responses. Company-owned sources (Corebridge public pages) and independent sources (review sites, broker guides, and third-party publications) are distinguished throughout. No personal testing, customer experience, or independent verification of platform claims was performed.

Methodology Limitations

  • All platform findings are platform-reported and were not independently verified. Citations reflect what platforms retrieved or asserted, not confirmed facts.
  • Platform-reported research dates differ from the authoritative run date: deepseek reported 2026-04-25, while the other six platforms reported 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.
  • Platform mentions in the ranking stage count only platforms that named Corebridge during ranking discovery; all seven platforms evaluated fit, so fit-stage coverage exceeds ranking-stage coverage.
  • No platform found a Corebridge-published, heart-attack-specific underwriting manual, waiting period, coverage ceiling, ejection-fraction threshold, or rating schedule. Missing research is not evidence of absence.
  • Product names and availability may differ between Corebridge, AIG Direct/Corebridge Direct, issuing insurers, states, and distribution channels. Conflicting product names were not resolved by guessing.
  • The supplied source URLs were collected from platform responses and were not independently validated by the writer stage.
  • Deepseek's research ran without search enabled, so its claims are model-reported rather than retrieved.
  • Platform agreement does not prove product quality, and no claim here should be read as a guarantee of acceptance, pricing, or performance.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • Additional AI research evidence85 records
    1. AI research evidence record grok:4
    2. AI research evidence record openai:c1
    3. AI research evidence record deepseek:c1
    4. AI research evidence record anthropic:1-3
    5. AI research evidence record anthropic:1-11
    6. AI research evidence record anthropic:35-11
    7. AI research evidence record google:1.1.6
    8. AI research evidence record anthropic:1-14
    9. AI research evidence record anthropic:39-13
    10. AI research evidence record deepseek:c3
    11. AI research evidence record openai:c1
    12. AI research evidence record perplexity:c1
    13. AI research evidence record google:3.2.9
    14. AI research evidence record anthropic:8-7
    15. AI research evidence record openai:c2
    16. AI research evidence record anthropic:28-1
    17. AI research evidence record perplexity:c5
    18. AI research evidence record perplexity:c6
    19. AI research evidence record openai:c4
    20. AI research evidence record anthropic:6-4
    21. AI research evidence record anthropic:1-5
    22. AI research evidence record anthropic:2-1
    23. AI research evidence record anthropic:9-10
    24. AI research evidence record anthropic:2-2
    25. AI research evidence record openai:c1
    26. AI research evidence record perplexity:c1
    27. AI research evidence record google:3.2.9
    28. AI research evidence record anthropic:8-7
    29. AI research evidence record openai:c2
    30. AI research evidence record anthropic:8-8
    31. AI research evidence record anthropic:8-10
    32. AI research evidence record google:3.2.6
    33. AI research evidence record perplexity:c5
    34. AI research evidence record perplexity:c6
    35. AI research evidence record openai:c3
    36. AI research evidence record anthropic:21-1
    37. AI research evidence record deepseek:c2
    38. AI research evidence record anthropic:39-13
    39. AI research evidence record deepseek:c3
    40. AI research evidence record google:1.1.4
    41. AI research evidence record google:3.1.4
    42. AI research evidence record grok:0
    43. AI research evidence record anthropic:29-5
    44. AI research evidence record anthropic:29-6
    45. AI research evidence record anthropic:31-1
    46. AI research evidence record anthropic:32-2
    47. AI research evidence record anthropic:32-3
    48. AI research evidence record anthropic:32-10
    49. AI research evidence record google:1.2.5
    50. AI research evidence record anthropic:21-1
    51. AI research evidence record anthropic:28-1
    52. AI research evidence record anthropic:24-7
    53. AI research evidence record anthropic:24-8
    54. AI research evidence record grok:4
    55. AI research evidence record grok:2
    56. AI research evidence record grok:3
    57. AI research evidence record anthropic:11-14
    58. AI research evidence record perplexity:c2
    59. AI research evidence record anthropic:18-2
    60. AI research evidence record anthropic:18-6
    61. AI research evidence record anthropic:18-8
    62. AI research evidence record anthropic:28-5
    63. AI research evidence record anthropic:2-1
    64. AI research evidence record anthropic:9-10
    65. AI research evidence record anthropic:6-4
    66. AI research evidence record anthropic:1-5
    67. AI research evidence record openai:c1
    68. AI research evidence record openai:c5
    69. AI research evidence record anthropic:42-2
    70. AI research evidence record anthropic:11-9
    71. AI research evidence record anthropic:11-10
    72. AI research evidence record anthropic:43-2
    73. AI research evidence record google:1.2.5
    74. AI research evidence record kimi:c3
    75. AI research evidence record grok:0
    76. AI research evidence record openai:c5
    77. AI research evidence record kimi:c1
    78. AI research evidence record openai:c1
    79. AI research evidence record openai:c2
    80. AI research evidence record google:3.2.5
    81. AI research evidence record anthropic:40-11
    82. AI research evidence record anthropic:40-12
    83. AI research evidence record anthropic:41-1
    84. AI research evidence record anthropic:40-4
    85. AI research evidence record anthropic:40-5

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
43
Ranking mentions
3 of 7
Platform share
43%
Final consensus rank
#6

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

27 independent · 15 company-owned · 1 unclear

Evidence support

39 direct · 4 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

e75a201ee7e087ca58d24876b91626ab2e0ecaff30aba5d24543e6161ce2660b